130 related articles for article (PubMed ID: 3462303)
1. HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism.
Schreuder GM; Tilanus MG; Bontrop RE; Bruining GJ; Giphart MJ; van Rood JJ; de Vries RR
J Exp Med; 1986 Sep; 164(3):938-43. PubMed ID: 3462303
[TBL] [Abstract][Full Text] [Related]
2. TA10 and 2B3, two new alleles in the HLA-DQ region recognized by monoclonal antibodies.
Schreuder GM; Maeda H; Koning F; D'Amaro J
Hum Immunol; 1986 Jun; 16(2):127-36. PubMed ID: 2424871
[TBL] [Abstract][Full Text] [Related]
3. Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.
Tilanus MG; Morolli B; van Eggermond MC; Schreuder GM; de Vries RR; Giphart MJ
Immunogenetics; 1986; 23(5):333-40. PubMed ID: 3011659
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms within the HLA-DR4 haplotypes. Various DQ subtypes detected with monoclonal antibodies.
Bontrop RE; Schreuder GM; Mikulski EM; van Miltenburg RT; Giphart MJ
Tissue Antigens; 1986 Jan; 27(1):22-31. PubMed ID: 3006281
[TBL] [Abstract][Full Text] [Related]
5. Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.
Bontrop RE; Baas EJ; Otting N; Schreuder GM; Giphart MJ
Immunogenetics; 1987; 25(5):305-12. PubMed ID: 3570381
[TBL] [Abstract][Full Text] [Related]
6. HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis.
Sansom DM; Bidwell JL; Maddison PJ; Campion G; Klouda PT; Bradley BA
Hum Immunol; 1987 Aug; 19(4):269-78. PubMed ID: 2445715
[TBL] [Abstract][Full Text] [Related]
7. New HLA DNA polymorphisms associated with rheumatoid arthritis.
Cutbush SD; Ollier W; Awad J; Currey HL; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):173-83. PubMed ID: 2898314
[TBL] [Abstract][Full Text] [Related]
8. Molecular variation of human major histocompatibility complex DQw3 beta-chains.
So AK; Lindsay J; Bodmer J; Trowsdale J
J Immunol; 1987 Nov; 139(10):3506-11. PubMed ID: 2890689
[TBL] [Abstract][Full Text] [Related]
9. HLA class II DR, DQ, and DP restriction fragment length polymorphisms in rheumatoid arthritis.
Howell WM; Evans PR; Wilson PJ; Cawley MI; Smith JL
Ann Rheum Dis; 1989 Apr; 48(4):295-301. PubMed ID: 2565707
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis.
Lanchbury JS; Sakkas LI; Marsh SG; Bodmer JG; Welsh KI; Panayi GS
Hum Immunol; 1989 Sep; 26(1):59-71. PubMed ID: 2789210
[TBL] [Abstract][Full Text] [Related]
11. Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ beta-chain gene.
Kim SJ; Holbeck SL; Nisperos B; Hansen JA; Maeda H; Nepom GT
Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8139-43. PubMed ID: 2999795
[TBL] [Abstract][Full Text] [Related]
12. Analysis of HLA class II polymorphism using polymerase chain reaction.
Erlich H; Bugawan T; Begovich A; Scharf S
Arch Pathol Lab Med; 1993 May; 117(5):482-5. PubMed ID: 8489336
[TBL] [Abstract][Full Text] [Related]
13. A deletion mutant defines DQ beta variants with DR4 positive DQw3 positive haplotypes.
Nepom BS; Kim SJ; Nepom GT
Hum Immunol; 1986 Oct; 17(2):87-93. PubMed ID: 2875977
[TBL] [Abstract][Full Text] [Related]
14. Unambiguous typing for HLA-DQ TA10 and 2B3 specificities using specific oligonucleotide probes.
Kenter MJ; Anholts JD; Schreuder GM; van Eggermond MC; Ghyselen GM; van Rood JJ; Giphart MJ
Hum Immunol; 1989 Jan; 24(1):65-73. PubMed ID: 2492489
[TBL] [Abstract][Full Text] [Related]
15. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes.
Böhme J; Carlsson B; Wallin J; Möller E; Persson B; Peterson PA; Rask L
J Immunol; 1986 Aug; 137(3):941-7. PubMed ID: 2424992
[TBL] [Abstract][Full Text] [Related]
16. DR2+ haplotypes in insulin-dependent diabetes: analysis of DNA restriction fragment length polymorphisms.
Segall M; Noreen H; Schluender L; Swenson M; Barbosa J; Bach FH
Hum Immunol; 1986 Sep; 17(1):61-8. PubMed ID: 3017902
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR antigens and HLA-DQ beta chain polymorphism in susceptibility to rheumatoid arthritis.
Ilonen J; Reijonen H; Arvilommi H; Jokinen I; Möttönen T; Hannonen P
Ann Rheum Dis; 1990 Jul; 49(7):494-6. PubMed ID: 1974413
[TBL] [Abstract][Full Text] [Related]
18. Identification of an HLA-DQ beta-chain related genomic sequence associated with insulin-dependent diabetes.
Michelsen B; Kastern W; Lernmark A; Owerbach D
Biomed Biochim Acta; 1985; 44(1):33-6. PubMed ID: 2986612
[TBL] [Abstract][Full Text] [Related]
19. DR4 and susceptibility to type I diabetes mellitus: discrimination of high risk and low risk DR4 haplotypes on the basis of TA10 typing.
Tait BD; Boyle AJ
Tissue Antigens; 1986 Aug; 28(2):65-71. PubMed ID: 3489301
[TBL] [Abstract][Full Text] [Related]
20. Southern hybridization analysis of DNA polymorphism in the HLA-D region.
Inoko H; Ando A; Ito M; Tsuji K
Hum Immunol; 1986 Jul; 16(3):304-13. PubMed ID: 3013815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
